eslicarbazepine acetate (ESL) when used as monotherapy for 1 year or more in routine
clinical use in patients with focal seizures in epilepsy clinics in Spain. Methods This is a
retrospective, observational, noninterventional study. Eligible patients were aged≥ 18
years, had focal seizures, and started on ESL≥ 1 year before database closure. Primary
endpoint was the following: proportion seizure-free for≥ 6 months at 1 and 2 years …